HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohmori, Y. Articles by Hamilton, T. A. Search for Related Content PubMed PubMed Citation Articles by Ohmori, Y. Articles by Hamilton, T. A. Social Bookmarking                      What's this?

Volume 272, Number 23, Issue of June 6, 1997 pp. 14899-14907
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Synergy between Interferon- and Tumor Necrosis Factor- in Transcriptional Activation Is Mediated by Cooperation between Signal Transducer and Activator of Transcription 1 and Nuclear Factor B^*

(Received for publication, July 30, 1996, and in revised form, March 3, 1997)

Yoshihiro Ohmori ^§, Robert D. Schreiber ^¶ and Thomas A. Hamilton

From the  Department of Immunology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195 and the ^¶ Center for Immunology, Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110

ABSTRACT

INTRODUCTION

EXPERIMENTAL PROCEDURES

RESULTS

DISCUSSION

FOOTNOTES

REFERENCES

ABSTRACT

Interferon- (IFN) and tumor necrosis factor- (TNF) cooperate to induce the expression of many gene products during inflammation. The present report demonstrates that a portion of this cooperativity is mediated by synergism between two distinct transcription factors: signal transducer and activator of transcription 1 (STAT1) and nuclear factor B (NF-B). IFN and TNF synergistically induce expression of mRNAs encoding interferon regulatory factor-1 (IRF-1), intercellular adhesion molecule-1, Mig (monokine induced by -interferon), and RANTES (regulated on activation normal T cell expressed and secreted) in normal but not STAT1-deficient mouse fibroblasts, indicating a requirement for STAT1. Transient transfection assays in fibroblasts using site-directed mutants of a 1.3-kilobase pair sequence of the IRF-1 gene promoter revealed that the synergy was dependent upon two sequence elements; a STAT binding element and a B motif. Artificial constructs containing a single copy of both a STAT binding element and a B motif linked to the herpes virus thymidine kinase promoter were able to mediate synergistic response to IFN and TNF; such response varied with both the relative spacing and the specific sequence of the regions between these two sites. Cooperatively responsive sequence constructs bound both STAT1 and NF-B in nuclear extracts prepared from IFN- and/or TNF-stimulated fibroblasts, although binding of individual factors was not cooperative. Thus, the frequently observed synergy between IFN and TNF in promoting inflammatory response depends in part upon cooperation between STAT1 and NF-B, which is most likely mediated by their independent interaction with one or more components of the basal transcription complex.

---

INTRODUCTION

Intercellular communication by cytokines during an inflammatory reaction is integral to the subsequent orchestration and resolution of the response. IFN¹ and TNF are pleiotrophic cytokines that play often critical roles in this process (1, 2). Although both cytokines independently exert a number of biological activities in a cell type-specific fashion, they have been shown in many circumstances to function cooperatively or antagonistically in controlling expression of a variety of cytokines and cell surface molecules (3-7).

Much recent work on cytokine-mediated intracellular signaling pathways has provided a general paradigm for the molecular mechanisms by which extracellular signals induce transcription of target genes (8-11). A variety of cytokines, growth factors, and hormones trigger phosphorylation of latent cytoplasmic transcription factors termed signal transducers and activators of transcription (STATs) via one or more members of the Janus (Jak) family of protein tyrosine kinases. Tyrosine-phosphorylated STATs assemble in dimeric or oligomeric form, translocate to the nucleus, and bind to specific DNA sequence motifs or STAT binding elements (SBEs) (12). IFN has been shown to induce tyrosine phosphorylation of STAT1, and a homodimeric form of STAT1 binds to the IFN-activation sequence (13), an SBE that has been identified as a critical sequence motif involved in the transcriptional activation of many IFN-inducible genes including the IRF-1 and ICAM-1 genes (14-17).

The B sequence motif has been shown to be an essential cis-acting regulatory element for mediating the TNF-, interleukin-1-, and lipopolysaccharide-induced transcriptional activation of multiple cytokines and cell surface molecules (18-20). Although this sequence motif is recognized by members of the Rel homology family, including NF-B1 (p50/p105), NF-B2 (p52/p100), RelA, c-Rel, and RelB, various forms of the B sequence motif have been shown to exhibit differential affinity for and functional response to different dimeric combinations of Rel family proteins. Cell type-specific expression of the Rel family members also mediates specificity for B-dependent gene expression. Furthermore, members of the Rel family have been shown to physically and functionally interact with members of other transcription factor families (21-23). The combination of these variables generates high potential for diversity in the control of gene expression during inflammation.

Components of the JAK-STAT and the B signaling pathways appear to be indispensable for stimulus-dependent, transcriptional activation of many inflammatory genes. Furthermore, SBE and B motifs are found in the promoter regions of many inflammatory genes. Many studies have reported functional synergy between TNF and IFN in promoting inflammatory function and gene expression, some of which could involve an interplay between STAT1 and B binding factors (3-6). The present study was undertaken to determine whether IFN-activated STAT1 can cooperate with TNF-induced NF-B to promote enhanced transcription. The results show that IFN and TNF synergize to induce expression of several genes that contain both SBE and B motifs. The findings indicate that both the SBE and B motifs are required for cooperativity and that the synergistic function of STAT1 and NF-B appear to result from independent activation and recognition of cognate nucleotide sequence motifs.

---

EXPERIMENTAL PROCEDURES

Reagents

Dulbecco's modified Eagle's medium, minimum essential medium nonessential amino acid solution, sodium pyruvate, and antibiotic were obtained from Life Technologies, Inc. Fetal bovine serum was purchased from Bio Whittaker (Walkersville, MA). DEAE-dextran and polydeoxyinosinic-deoxycytidylic acid (poly(dI-dC)) were purchased from Pharmacia LKB Ltd. (Uppsala, Sweden). MAGNA Nylon transfer membrane was obtained from Micron Separations Inc. (Westboro, MA). Restriction enzymes, Klenow fragment of Escherichia coli DNA polymerase I, T4 kinase, and bovine serum albumin were purchased from Boehringer Mannheim. UlTma DNA polymerase was obtained from Perkin-Elmer. DuPont NEN was the source of [-³²P]dCTP and [-³²P]ATP. 1-Deoxy-dichloroacetyl-1-[¹⁴C]chloramphenicol was obtained from Amersham Corp. Thin layer chromatography (TLC) plates (Silica Gel 60) were obtained from Merck (Darmstadt, Germany). Protein assay reagents were obtained from Bio-Rad. Site-directed mutagenesis kits, the luciferase reporter plasmid (pGL2-Basic), and luciferase assay reagents were obtained from Promega Corp. (Madison, WI). Recombinant mouse IFN (specific activity, 6.8 × 10⁶ units/mg) was obtained from Life Technologies, Inc. Recombinant mouse TNF (specific activity, 2.6 × 10⁷ units/mg) was a generous gift from Genentech Inc. (South San Francisco, CA). Antisera to mouse p50 (NF-B1), p65 (RelA), c-Rel, STAT3, and human Sp1 were obtained from Santa Cruz Biotechnology (Hercules, CA). Mouse monoclonal antibody to human STAT1 (p91/p84) was obtained from Transduction laboratories (Lexington, KY). Dithiothreitol, HEPES, normal rabbit IgG, chloroquine diphosphate, dimethyl sulfoxide, leupeptin, antipain, aprotinin, pepstatin, and phenylmethylsulfonyl fluoride, were obtained from Sigma. Other reagents were purchased from Mallinckrodt, Inc. (Paris, KY).

Cell Culture

Fibroblasts from STAT1-deficient and wild type mice were prepared as described previously (24). These cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 10 mM nonessential amino acid solution, 10 mM sodium pyruvate, 20 mM of L-glutamine. NIH3T3 fibroblasts were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, glutamine, penicillin, and streptomycin (complete medium) and subcultured twice weekly. Prior to use in experiments, the cells were grown to confluence in 100- or 150-mm diameter culture dishes and then transferred to medium containing 0.2% fetal bovine serum for 24 h in order to deprive growth factor.

Preparation of Plasmid DNA

A cDNA encoding mouse IRF-1 (25) was cloned from a mouse macrophage cDNA library (26) using a reverse transcriptase-PCR fragment as a probe as described previously.² The plasmid encoding the cDNA for mouse ICAM-1 was obtained from the American Type Culture Collection (Rockville, MD) (27). cDNA fragments for mouse Mig and RANTES were prepared by reverse transcriptase-PCR using a set of primers corresponding to the mouse Mig and RANTES cDNA sequences obtained from the GenBank^TM data base (28-30) and subcloned into pBluescript (Stratagene, La Jolla, CA). The nucleotide sequences were independently confirmed. The plasmid encoding GAPDH was obtained from Dr. David Stern (Columbia University, New York, NY). Methods for plasmid DNA preparations were as described in Sambrook et al. (31). One µg of plasmid DNA or 100 ng of PCR products were radiolabeled by random priming with [-³²P]dCTP. The resultant specific activity was approximately 10⁸ cpm/µg, which was used at 10⁷ cpm/blot.

Preparation of RNA and Northern Hybridization Analysis

Each assay utilized confluent monolayer of fibroblasts cultured in 100-mm diameter plastic Petri dishes for preparation of total RNA. After treatment of the cells with the indicated stimuli, total cellular RNA was extracted by the guanidine isothiocyanate-cesium chloride method (32). Samples of total RNA (5 µg) were separated on a 1% agarose, 2.2 M formaldehyde gel and subsequently blotted onto MAGNA nylon membrane with 20 × SSC by capillary transfer according to previously published methods (31). The RNA was cross-linked to the membrane with a UV cross-linker (Stratagene). The blots were prehybridized for 8-12 h at 42 °C in 50% formamide, 1% SDS, 5 × SSC, 1 × Denhardt's solution (0.02% Ficoll, 0.02% bovine serum albumin, 0.02% polyvinylpyrrolidone), 0.25 mg/ml denatured salmon sperm DNA, and 50 mM sodium phosphate (pH 6.5) and then hybridized with 1 × 10⁶ cpm/ml of radiolabeled cDNA plasmid probe at 42 °C for 16-24 h. After hybridization, blots were washed with 0.1% SDS, 2 × SSC for 30 min at room temperature followed by two washes at 55 °C. The blots were then exposed using XAR-5 x-ray film with intensifying screens at 70 °C.

Preparation of Reporter Gene Plasmid DNA

The luciferase reporter constructs containing the 1.3-kb IRF-1 promoter was kindly provided by Dr. Bryan Williams (Department of Cancer Biology, Cleveland Clinic Foundation). The SBE site at positions 123 to 113 and the B site at positions 49 to 40 of the IRF-1 promoter (14) were respectively mutated in the 1.3-kb 5-flanking sequence of the IRF-1 gene by oligonucleotide-directed, site-specific mutagenesis as described previously (33). The mutant sequence utilized for the SBE and the B were TTCCCtcc and GtGGAATCaC, respectively. Lowercase letters represent the mutant nucleotides.

One or two copies of the IRF-1 SBE or the IP-10 B2 were placed in front of the 105 or the 81 base pair herpes simplex virus-thymidine kinase (TK) promoter (34) linked to the chloramphenicol acetyl transferase (CAT) gene (pTK-105 CAT) (35) or the luciferase gene (pTK-105 Luc or pTK-81 Luc) (36). These constructs were prepared by ligating the synthetic oligonucleotides (see below) into restriction enzyme sites of the reporter plasmids. To generate constructs containing different nucleotide spacing between the IRF-1 SBE and the B2 sites, one or more SalI linkers (GGTCGACC) were placed between the two sites. The sequences of these reporter gene constructs were confirmed.

Transient Transfection

Transfection of the luciferase and the CAT reporter genes into fibroblasts or NIH3T3 cells were as described previously (5). Briefly, the cells were seeded at a density of 3 × 10⁶ cells/150-mm diameter dish 24 h prior to transfection. 30 µg of reporter luciferase construct plasmid DNA were transfected by the DEAE-dextran method (300 µg/ml DEAE-dextran) for 20 min at room temperature. After the incubation, the cells were subjected to dimethyl sulfoxide shock for 1 min (10% dimethyl sulfoxide in phosphate-buffered saline), washed with phosphate-buffered saline, replenished with fresh culture medium, and cultured for 2 h. To standardize transfection efficiencies, the transfected cells were then harvested in trypsin-EDTA solution, pooled, and seeded in four 100-mm diameter Petri dishes. The cells were cultured in medium containing 0.2% fetal bovine serum for 24 h to deprive growth factors and then stimulated with IFN and/or TNF for 16 h for the CAT reporter gene and for 8 h for the luciferase reporter gene, respectively. After stimulation, the cells were washed and extracted in lysis buffer (Promega), and luciferase activity was assayed using reagents provided by Promega according to the manufacturer's instructions. Twenty µg of extract protein were utilized in each assay. CAT activity was assessed by determination of the conversion of [¹⁴C]chloramphenicol into acetylated forms detected by thin layer chromatography as described previously (35). The acetylated products were quantified using a phosphorescence detection system (Molecular Dynamics, Sunnyvale, CA).

Preparation of Oligonucleotides and PCR-amplified DNA

The following oligonucleotides were used in this study.

IRF-1 SBE	5-tcgaGCCTGATTTCCCCGAAATGACGGC-3
	3-CGGACTAAAGGGGCTTTACTGCCGagct-5
mut1 SBE	5-tcgaGCCTGATTTCCCCGCCATGACGGC-3
(m1 SBE)	3-CGGACTAAAGGGGCGGTACTGCCGagct-5
mut2 SBE	5-tcgaGCCTGATTGAATTCCAATGACGGC-3
(m2 SBE)	3-CGGACTAACTTAAGGTTACTGCCGagct-5
IRF-1 B	5-tcgaGCTGGGGAATCCCGCT-3
	3-CGACCCCTTAGGGCGAagct-5
mutIRF-1B (antisense)	3-GCCGGTCCCGACACCTTAGTGCGATTCACAAA-5
IP-10 B2	5-gatcGAGGGGAGAGGGAAATTCCAAGTTCATG-3
	3-CTCCCCTCTCCCTTTAAGGTTCAAGTACctag-5
mutIP-10 B2	5-gatcGAGGGGAGAGTGAAATTACAAGTTCATG-3
	3-CTCCCCTCTCACTTTAATGTTCAAGTACctag-5
OLIGONUCLEOTIDES 1-7

The nucleotide sequences of IRF-1 SBE and B were taken from Sims et al. (14). The IP-10 B2 sequence was taken from Ohmori and Hamilton (33, 37). Lowercase letters represent the bases included for creating restriction sites. Underlined sequences represent the consensus sequences for the SBE and B elements, respectively. Boldface type indicates the substituted bases for mutation. Oligonucleotides were synthesized using an Applied Biosystem DNA synthesizer (model 381A) or obtained from Ransom Hill Bioscience Inc. (Ramona, CA). Double-stranded oligonucleotides were prepared by annealing the complementary single strands. A DNA fragment corresponding to the region between 129 and 37 of the IRF-1 promoter (14) was generated by PCR using a sense oligonucleotide of the IRF-1 SBE and an antisense oligonucleotide of the IRF-1 B as primers, and the luciferase reporter plasmid containing the 1.3-kb IRF-1 promoter was used as a template. A mutant fragment was also generated by using a sense oligonucleotide of mut1 SBE and antisense oligonucleotide mutIRF-1B as described above. Double-stranded oligonucleotides were radiolabeled with the Klenow fragment of DNA polymerase I and [-³²P]dCTP in a fill-in reaction for 5 protruding ends. PCR-amplified DNA fragments were radiolabeled with T4 kinase and [-³²P]ATP.

Preparation of Nuclear Extracts

Nuclear extracts were prepared using a modification of the method of Dignam et al. (38) as described previously (5, 37). After stimulation, the cells were washed with ice-cold phosphate-buffered saline three times, harvested, and resuspended in 300 µl of hypotonic buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 10 µg/ml of leupeptin, antipain, aprotinin, and pepstatin) for 10 min on ice. The cells were then lysed in 0.6% Nonidet P-40 by vortexing for 10 s. Nuclei were separated from cytosol by centrifugation at 12,000 × g for 30 s, washed with 300 µl of buffer A, and resuspended in buffer C (20 mM HEPES, pH 7.9, 25% glycerol, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 10 µg/ml of leupeptin, antipain, aprotinin, and pepstatin) and briefly sonicated on ice. Nuclear extracts were obtained by centrifugation at 12,000 × g for 10 min. Protein concentration was measured by the method of Bradford (39) by using the protein dye reagent (Bio-Rad).

Electrophoretic Mobility Shift Assay (EMSA)

For binding reactions, nuclear extracts (5 µg of protein) were incubated in 12.5 µl of total reaction volume containing 20 mM HEPES (pH 7.9), 50 mM KCl, 0.1 mM EDTA, 1 mM dithiothreitol, 5% glycerol, 200 µg/ml bovine serum albumin, and 1.25 µg of poly(dI-dC) for 15 min at 4 °C. The ³²P-labeled oligonucleotide (~5 × 10⁵ cpm) was then added to the reaction mixture and incubated for 20 min at room temperature. In some experiments, antibodies against NF-B1, RelA, c-Rel, STAT1, STAT3, and Sp1 were included in the reaction mixture. The reaction products were analyzed by electrophoresis in a 4% polyacrylamide gel with 0.25 × TBE buffer (22.3 mM Tris, 22.2 mM borate, 0.5 mM EDTA). The gels were dried and analyzed by autoradiography.

---

RESULTS

STAT1 Is Essential for the Synergistic Induction of IFN and TNF-mediated Gene Expression

IFN and TNF have been shown to cooperatively regulate transcription of many inflammatory genes (3-6, 40). Previous studies have demonstrated that the IFN-induced transcriptional activation of the IRF-1, ICAM-1, and Mig genes depends upon IFN response elements or SBEs in the promoter region of the genes (Fig. 1), which are recognized by STAT1 or STAT1-containing factor(s) (14-17, 41-43). The promoter regions of these IFN-inducible genes also contain one or more B sequence motifs, and their transcriptional activation in response to TNF is dependent upon activation of B binding activities (44, 45). On the basis of these observations, we postulated that IFN-induced STAT1 and TNF-induced NF-B cooperatively regulate transcription of genes containing both SBE and B motifs. Analysis of RANTES gene expression was also included, since IFN and TNF can cooperatively induce expression of this chemokine gene, although no SBE has been identified in the promoter (6, 30, 46-48). Levels of endogenous mRNA expression were determined in fibroblasts from wild-type mice or from mice in which the STAT1 gene has been deleted through homologous recombination (24). Serum-starved cultures were stimulated with IFN and TNF either alone or in combination for 3 h prior to isolation of RNA and Northern analysis. While the sensitivity of normal cells to IFN or TNF alone varied with each gene, all four genes were strongly expressed in cells stimulated with both agents (Fig. 2A). IFN and TNF cooperativity was markedly reduced (>90%) in STAT1-deficient fibroblasts without affecting the sensitivity to TNF alone (Fig. 2B). These four responses were not mechanistically identical; the synergistic enhancement of RANTES mRNA expression was blocked in cells co-treated with cycloheximide (CHX), while expression of IRF-1, ICAM-1, and Mig was unaltered (Fig. 2C). Thus, the synergy between IFN and TNF may involve protein synthesis-dependent and -independent mechanisms, both of which require IFN-induced STAT1.

---

Fig. 1. Schematic representation of the promoter region of the IRF-1, ICAM-1, Mig, and RANTES genes. Potential cis-regulatory elements and critical defined sequences are schematically shown based on gene sequences obtained from the GenBank^TM data base and the following references; human IRF-1 (14, 15, 49); human ICAM-1 (16, 17, 44, 45, 68); mouse Mig (41, 42); mouse RANTES (30, 46). The numbers above the promotor regions refer to the nucleotide position relative to the transcription start site.
[View Larger Version of this Image (20K GIF file)]

---

---

Fig. 2. STAT1 is essential for optimal synergy between IFN and TNF. Serum-starved confluent monolayers of fibroblasts from wild type mice (A) or STAT1-deficient mice (B) were either untreated (UT) or stimulated with IFN (100 units/ml) and/or TNF (10 ng/ml) for 3 h in the presence or absence of cycloheximide (C, CHX; 5 µg/ml) prior to preparation of total RNA and analysis of specific mRNA levels by Northern hybridization as described under "Experimental Procedures." Five µg of total RNA were analyzed in each lane. Blots were hybridized with the indicated radiolabeled cDNA probes. Similar results were obtained in three independent experiments.
[View Larger Version of this Image (58K GIF file)]

---

IFN/TNF-induced Cooperative Transcription of the IRF-1 Gene Depends upon both the SBE and B Sites

IFN-induced transcription of the IRF-1 gene has been shown to depend upon the SBE located in positions 123 to 113 (14, 15). A highly conserved B motif has also been identified, although its functional significance remains equivocal (Fig. 1) (14, 49, 50). To determine if cooperation between IFN and TNF for induction of the IRF-1 gene depends upon one or both of these sites, luciferase reporter gene constructs of the IRF-1 promoter (1.3 kb) were prepared in which the SBE and/or the proximal B site were individually mutated. These constructs were transiently transfected into wild type or STAT1-deficient fibroblasts, and their activity was assessed following treatment with IFN and/or TNF (Fig. 3). As reported previously, IFN markedly induced luciferase activity in normal fibroblasts transfected with the wild type 1.3-kb IRF-1 promoter construct (14, 15). TNF also modestly induced luciferase activity (5-7-fold induction). When cells were simultaneously stimulated with IFN and TNF, the promoter activity was synergistically enhanced. Mutation of the SBE site nearly abolished the IFN sensitivity and markedly reduced the cooperative response to the combination of IFN and TNF (85% reduction in magnitude) without affecting the TNF-induced luciferase activity. Similarly, the mutation of the B site abolished the response to TNF alone and reduced the cooperativity for IFN and TNF (77% reduction in magnitude). Mutation of both the SBE and the B site in the same construct nearly eliminated sensitivity to either stimulus alone, and the cooperative response, although evident, was only 3% of that seen in cells transfected with the intact promoter. Furthermore, in STAT1-deficient fibroblasts, response to IFN either alone or in combination with TNF was less than 5% of the response seen in wild type cells. Taken together, these results indicate that both the SBE and the B sequence motifs are required for optimal cooperativity between IFN and TNF and that activation of STAT1, at least, is also necessary.

---

Fig. 3. The B and SBE sites in the 1.3-kb promoter of the IRF-1 gene are required for optimal IFN and TNF-induced transcriptional activity. The diagram at the left shows wild type and mutant 1.3-kb IRF-1 luciferase constructs. Potential enhancer elements are shown schematically. The numbers above the enhancer elements refer to the nucleotide position relative to the transcription start site of the IRF-1 gene (14). Fibroblasts from wild type mice (top part) or from STAT1-deficient mice (bottom part) were transfected with the indicated luciferase constructs as described under "Experimental Procedures." Twenty-four hours after transfection, the cells were either left untreated or stimulated with IFN (100 units/ml) and/or TNF (10 ng/ml) for 8 h prior to analysis of luciferase activity. The relative luciferase activity is expressed as -fold induction in stimulated as compared with unstimulated samples. Mean arbitrary luciferase units (units/µg) for different constructs in unstimulated cultures are as follows: pGL Basic, 0.2; pGL IRF-1, 1.3; mut SBE, 2.8; mut B, 3.9, mut SBE + B, 1.2. Each column and bar represents the mean ± S.E. from four independent experiments.
[View Larger Version of this Image (22K GIF file)]

---

While the magnitude of cooperative response is markedly reduced in wild type cells transfected with mutations in individual motifs (either SBE or B) and in STAT1-deficient cells, there is residual cooperativity evident in both circumstances. This apparent leakiness may derive from multiple sources. For example, the mutated motifs may retain some low affinity interaction with individual factors. Alternatively, there may be other sites that are able to participate, providing the lower magnitude cooperativity. Indeed, low but detectable cooperativity is evident using promoter constructs in which both the SBE and the proximal B sites are mutated. The very low but reproducible response to IFN seen in STAT1-deficient cells (both in Fig. 1 and Fig. 3) may reflect minor compensatory action of IFN functioning through STAT1-independent systems. Indeed, in EMSA experiments using nuclear extracts from IFN-treated STAT1-deficient fibroblasts, we detected low but significant levels of STAT3 that were not seen in wild type cells (data not shown). Since STAT3 can act to modulate transcription through IFN activation sequence motifs, this could account for the leaky response to IFN. It should be emphasized that these low level responses may detectable in our experimental system due to the very high sensitivity of the luciferase reporter gene.

Binding of IFN-induced STAT1 and TNF-induced NF-B Is Not Cooperative

IFN is well documented to stimulate the phosphorylation and nuclear localization of STAT1 homodimers (8-11). Similarly, TNF is a potent stimulus of the nuclear translocation of various members of the Rel homology family (18-20). The functional cooperativity between IFN and TNF might result from cooperative effects on DNA binding activities of the respective transcription factors. Thus, we next compared the binding activities of STAT1 and NF-B to their respective sequence motifs using nuclear extracts prepared from cells stimulated with IFN and/or TNF for 30 min by EMSA (Fig. 4). Although nuclear extracts from fibroblasts stimulated with IFN showed little or no inducible B binding activity, cells stimulated with TNF exhibited two inducible complexes designated as C1 and C2 in Fig. 4A. When cultures were co-stimulated with IFN and TNF, the magnitude of the binding activity and pattern of complex formation were essentially the same as seen in cells stimulated with TNF alone. As shown in Fig. 4B, the C1 complex was fully reactive with antiserum specific for NF-B1, while the C2 complex showed partial reactivity with anti-NF-B1 and full reactivity with antiserum specific for RelA. Antibodies specific for c-Rel and STAT1 did not recognize any of the IFN- and/or TNF-induced B binding activities. These results suggest that the binding activity induced by TNF that recognizes the IRF-1 B site is composed of NF-B1/RelA heterodimers and RelA homodimers. Specificity for the Rel protein binding was further assessed by oligonucleotide competition assays (Fig. 4C). Oligonucleotides containing the wild type IRF-1 B motif competed effectively for the binding of these Rel proteins, while a mutant oligonucleotide was inactive (lanes 2 and 3). Interestingly, oligonucleotides containing a wild type IRF-1 SBE or a mutant SBE in which two adenine residues in the 3 half of the inverted repeat were changed (m1 SBE) also partially competed for the binding of NF-B1 and RelA (lanes 4 and 5). Another mutant SBE (m2 SBE), in which the intervening sequence between the inverted repeats was also altered, could not compete for binding to the B motif. Since the adenine residues in the inverted repeat have been previously shown to be critical for recognition by STAT1 (14), sequence preferences for STAT1 and NF-B appear to be distinct. This ability of SBE to compete for NF-B recognition may result from the B-like site in the 5 portion of the IRF-1 SBE motif. In addition it may reflect the low affinity recognition of SBEs by NF-B as previously reported (51).

---

Fig. 4. NF-B1 (p50) and RelA (p65) bind to the IRF-1 proximal B site in TNF-induced fibroblasts. A, fibroblasts from wild type mice were either untreated (UT) or treated with IFN (100 units/ml) and/or TNF (10 ng/ml) as indicated for 30 min prior to the preparation of nuclear extracts. Five µg of each nuclear extract were analyzed for B binding activity by EMSA using a radiolabeled oligonucleotide containing the IRF-1 B sequence motif. Two major complexes are indicated as C1 and C2. B, nuclear extracts from IFN and TNF-stimulated cells were incubated with the indicated antibodies (1 µg) before analysis of the B binding activity as described above. C, competition analysis of IRF-1 B binding activity. Specificity of binding was assessed by competition with a 50-fold molar excess of unlabeled wild type or mutant oligonucleotide corresponding to the B or SBE motifs as shown at the bottom. Mutated nucleotides are indicated in italic type. Underlined sequences represent the B and SBE motifs, respectively. The overlined sequence indicates a potential B motif contained within the SBE site. An oligonucleotide fragment corresponding to the region between 129 and 37 (SBE-B) or an oligonucleotide fragment in which both the SBE and the B sites have been mutated (mSBE-mB) was also used as a competitor. Nuclear extracts (5 µg) from wild type fibroblasts treated with IFN (100 units/ml) and TNF (10 ng/ml) for 30 min were analyzed. Similar results were obtained from three independent experiments.
[View Larger Version of this Image (43K GIF file)]

---

Consistent with previous reports, nuclear extracts from IFN-treated fibroblasts contained a prominent stimulus-dependent DNA binding activity specific for the IRF-1 SBE (Fig. 5A), and this complex is fully reactive with antibody to STAT1 (data not shown). Interestingly, TNF also induced a DNA binding activity that recognized the IRF-1 SBE forming a complex that migrated at a slightly different mobility. This complex was reactive with antibodies specific for NF-B1 and RelA (Fig. 5B, lanes 3 and 4). These findings are also consistent with the results in Fig. 4C showing competition between the SBE and NF-B on the IRF-1 B site. When nuclear extracts from cells stimulated with both IFN and TNF were analyzed, a single broad band was observed, consistent with the presence of both the STAT1 and NF-B complexes seen with IFN or TNF stimulation alone. The most prominent component in this complex was STAT1, as indicated by immunoreactivity with anti-STAT1 (Fig. 5B, lane 6). The more slowly migrating complex, which was not reactive with anti-STAT1, was reactive with anti-NF-B1 and anti-RelA (lanes 8 and 9). Competition assays showed that an oligonucleotide containing a wild type SBE effectively competed for the binding of all complexes (Fig. 5C, lane 4), while the wild type B motif either did not compete or did so poorly (lane 2). The m1 SBE did not compete, indicating that most of the binding activity present was STAT1, since this mutation appears to affect primarily the formation of STAT1 complexes and not NF-B. A large DNA fragment containing both the SBE and the B sites was also able to compete complex formation in response to treatment with IFN and TNF. When this larger fragment (spanning positions 129 and 37 of the IRF-1 promoter) was used as a probe in EMSA, each complex was formed independently, and no evidence was obtained for cooperativity in binding between factors activated independently by IFN or TNF (data not shown).

---

Fig. 5. SBE binding activity in fibroblasts treated with IFN and TNF. A, fibroblasts from a wild type mouse were either untreated (UT) or treated with IFN (100 units/ml) and/or TNF (10 ng/ml) as indicated for 30 min prior to the preparation of nuclear extracts. Five µg of each nuclear extract were analyzed for DNA binding activity by EMSA using radiolabeled oligonucleotides containing the IRF-1 SBE sequence motif. B, nuclear extracts (5 µg) from wild type fibroblasts treated with IFN (100 units/ml) and/or TNF (10 ng/ml) for 30 min were incubated with the indicated antibodies before analysis of the SBE binding activity. C, competition analysis of IRF-1 SBE binding activity. Specificity of binding was assessed by competition with a 50-fold molar excess of unlabeled wild type or mutant oligonucleotide corresponding to the B or SBE motifs as described under "Experimental Procedures" and as shown in Fig. 4. A double-stranded oligonucleotide corresponding to the region between 129 and 37 (SBE-B) or an oligonucleotide in which the SBE and the B sites have been mutated (mSBE-mB) was also used as a competitor. Nuclear extracts (5 µg) from wild-type fibroblasts treated with IFN (100 units/ml) and TNF (10 ng/ml) for 30 min were analyzed. Similar results were obtained from three independent experiments.
[View Larger Version of this Image (39K GIF file)]

---

SBE and B Sequences Cooperate in an Artificial Promoter

To explore the generality of the B motif and SBE functional cooperativity, we asked whether transcriptional synergy could be reconstituted using isolated sequence elements placed in a heterologous promoter. Initially, one copy of the IRF-1 SBE and/or the B2 motif from the mouse IP-10 gene (33, 37) were placed in front of the TK promoter (TK-105) linked to the CAT reporter gene and tested for sensitivity to IFN and/or TNF following transient transfection in NIH3T3 cells (Fig. 6). Although one copy of the B2 motif exhibited little sensitivity to IFN or TNF either alone or in combination with the SBE, one copy of the IRF-1 SBE motif was sensitive to IFN or IFN and TNF. When a construct containing one copy each of the B2 and the SBE was analyzed, a strong synergistic response was seen in cells stimulated with the combination of agents. Mutation of the SBE site abolished all stimulus sensitivity of the combination construct and was essentially identical to that of a construct containing only a single B site. Thus cooperativity was not due to creation of fortuitous binding sites in the region where inserted sequences are coupled. Interestingly, cooperativity between IFN and TNF was also seen using the construct containing only the IRF-1 SBE and using the construct containing wild type SBE and mutant B. The synergistic response of such constructs to IFN and TNF appears to depend upon the distal portion of the TK promoter, which contains a GC box and a CCAAT box; no cooperativity was seen in a truncated form of the TK promoter in which the distal GC box and CCAAT box have been deleted (pTK-81, see Fig. 7).

---

Fig. 6. B and SBE motifs confer functional cooperativity on a heterologous promoter in response to IFN and TNF. One copy of a oligonucleotide corresponding to the wild type or mutant form of the IRF-1 SBE or the IP-10 B2 site (see "Experimental Procedures") was linked upstream of the TK-105 promoter (pTK-105) containing the CAT gene. The nucleotide length between the SBE and the B sites was 25 bases. The combination of the SBE and the B sequences are schematically indicated. These CAT constructs were transiently transfected into NIH3T3 cells as described under "Experimental Procedures." Twenty-four hours after transfection, the cells were either untreated or stimulated with IFN (100 units/ml) and/or TNF (10 ng/ml) for 16 h and assayed for CAT activity. The relative CAT activity is shown as -fold induction of stimulated versus unstimulated samples. Mean percentage of acetylation for different constructs in unstimulated cultures ranged from 0.2 to 0.4%. The maximum CAT activity was 27% acetylation, which was obtained in cultures transfected with pTK B2 + SBE and stimulated with IFN and TNF. Each column and bar represents the mean ± S.E. from three independent experiments.
[View Larger Version of this Image (22K GIF file)]

---

---

Fig. 7. Effect of motif order and spacing on IFN and TNF-induced cooperativity. One copy of an oligonucleotide corresponding to the IRF-1 SBE or the B2 motif from the IP-10 gene (see "Experimental Procedures") was placed in front of the TK-81 promoter linked to the luciferase gene (pTK-81 Luc) as indicated schematically. Constructs with increasing nucleotide spacing between the SBE and the B site were prepared as described under "Experimental Procedures." These constructs were transiently transfected into NIH3T3 cells, and following a 24-h rest, the cells were either untreated or stimulated with IFN (100 units/ml) and/or TNF (10 ng/ml) for 8 h prior to harvest and determination of luciferase activity. The relative luciferase activity is presented as a percentage of activity obtained in cells transfected with the pTK-81 SP25 B + SBE plasmid stimulated with IFN and TNF. The -fold induction of stimulated versus unstimulated samples is also indicated. Each column and bar represents the mean ± S.E. from three independent experiments.
[View Larger Version of this Image (26K GIF file)]

---

The spacial relationship between the two cooperating sites may be an important determinant of their synergistic interaction. To examine this possibility, reporter constructs in which the sequence motif orientation and the nucleotide spacing between motifs were varied were prepared and examined in transient assays (Fig. 7). For these experiments, a truncated form of the TK-luciferase vector (pTK-81) was utilized in which both a GC box (Sp1 binding site) and a CCAAT box have been deleted. When a single copy of either a B site or the IRF-1 SBE were linked to this reporter plasmid, no cooperative response was obtained. As mentioned above, this result suggests that the cooperative response seen with constructs containing a single SBE site (see Fig. 6) requires one or both of the sites deleted from the TK promoter. When a construct containing a single copy each of the SBE and the B motif was examined, a strong synergistic response was obtained. The synergy was not dependent upon the relative order of sites. Although constructs containing the SBE in either a distal or proximal relationship to the TK promoter exhibited variable response to IFN alone, cooperative responses were comparable (6-7-fold). The variability in sensitivity to IFN is also observed in Fig. 7 when comparing the response of pTK SBE and pTK mB2 + SBE, where the spacing of the SBE relative to the TK promoter is comparably altered. When the spacing between the two sites was incrementally increased, sensitivity to individual and combination stimulation was reduced. An increase of 5 nucleotides only modestly reduced the cooperativity, indicating that the orientation of bound factors relative to each other and the turn of the helix was not a limiting feature of the response. As the spacing interval was increased, the response was much more dramatically reduced. Interestingly, when the sites were separated by 64 nucleotides, a distance equivalent to that separating the SBE and B sites in the endogenous IRF-1 promoter, sensitivity to stimulation was lost entirely. These results indicate that while spacing may influence the magnitude of cooperativity, other features of the sequence between sites are probably of more critical importance.

---

DISCUSSION

IFN and TNF utilize distinct signaling pathways leading to altered gene transcription (8-11, 52). When these cytokines have been used in combination, both cooperative and antagonistic effects on gene transcription have been observed (3-7, 40). The present study was undertaken to define the mechanisms involved in such a synergistic response. The results demonstrate that STAT1 activation by IFN and NF-B activation by TNF are the principle events necessary for cooperative induction of genes containing appropriate SBE and B sequence motifs. Independent interaction of STAT1 and NF-B with their cognate binding sites is sufficient for mediating the cooperativity. These conclusions are based on the following observations. 1) IFN and TNF synergized strongly to promote expression of multiple genes that contain at least one copy of an SBE and a B site, including the IRF-1, ICAM-1, and Mig genes. 2) This activity was abolished in fibroblasts prepared from mice in which the STAT1 gene has been deleted by homologous recombination. 3) Synergistic transcription induced by IFN and TNF was observed in normal fibroblasts transfected with a reporter gene under control of a 1.3-kb fragment of the IRF-1 gene promoter. 4) The synergistic induction of the IRF-1 promoter activity was nearly abolished in a STAT1-deficient cell line. 5) Site-directed mutagenesis of the SBE and the proximal B site in the IRF-1 gene promoter significantly reduced the magnitude of the synergistic response. 6) IFN and TNF independently activated STAT1 and NF-B (NF-B1/RelA), respectively, as measured by binding to their cognate sequence motifs. 7) No cooperative effects on DNA binding activities were observed. 8) The SBE and B motifs could confer transcriptional synergy in response to IFN and TNF when examined in a heterologous promoter.

IFN-induced transcriptional synergy appears to be mediated by multiple pathways involving both protein synthesis-dependent and -independent mechanisms (5, 53). The results presented in this study indicate that cooperative effects involving IFN and TNF exhibit similar behavior (Fig. 2). An important observation is that both protein synthesis-dependent and -independent cooperativity still depends largely on STAT1, consistent with the recent reports showing STAT1 to be obligatory for IFN-mediated biological activities (24, 54). The requirement for protein synthesis during IFN/TNF-mediated RANTES gene expression suggests that some IFN-induced protein(s) (e.g. IRF-1) might be necessary for cooperativity in this circumstance, consistent with such roles for other genes (24, 53, 55). Inspection of the RANTES promoter sequence suggests the presence of IRF-binding motifs (56). Furthermore, functional B motifs have been identified in the promoter (Fig. 1) (46) and cooperative regulation of transcription by IRF-1 and NF-B has been previously reported (57, 58). In contrast, direct activation of STAT1, which may include the formation of STAT1 homodimers, heterodimers, or other oligomeric interactions, appears to be involved in the cooperative induction of IRF-1, ICAM-1, and Mig gene expression. IFN-dependent transcription of the IRF-1, ICAM-1, and Mig genes has been shown to depend upon SBE motifs that bind STAT1 in homo- or heterodimeric forms (14-17, 41-43). Furthermore, synergistic induction of IP-10 gene transcription by IFN and TNF also depends on an IFN-inducible factor that contains STAT1 and binds the IFN-stimulated response element found in the IP-10 promoter (5).

TNF is well documented as a potent inducer of NF-B and has been reported elsewhere to cooperate functionally with other transcription factors (5, 21, 23, 57, 58). The results in the present study indicate that NF-B (NF-B1/RelA) can cooperate with STAT1 to promote synergistic transcriptional activity. The proximal B site in the IRF-1 promoter is a functional B motif, which is recognized by a combination of NF-B1 and RelA in fibroblasts. TNF-mediated ICAM-1 gene transcription has been shown to depend upon a B motif recognized by Rel family members (44, 45). Interestingly, despite the fact that the Mig gene is not independently induced by stimuli that activate NF-B (e.g. TNF and lipopolysaccharide) (28), the cooperative induction of this gene by IFN and TNF suggests that the B motifs found in the Mig promoter are functional when STAT1 is also available.

Interestingly, we noted that the IRF-1 SBE appeared able to mediate a synergistic response to stimulation with IFN and TNF independently of the proximal B site (see Figs. 3 and 6). Since the SBE site was also recognized by STAT1 and NF-B, this dual recognition might contribute to the functional synergy. While this possibility cannot be ruled out, several considerations suggest that the cooperativity observed derives from other sources. For example, in Fig. 3, the constructs containing mutations in the SBE, in the B site, and in the double mutant all showed some synergistic response to the stimulus combination. Because this fragment is large (1.3 kb), there are apparently other independent sites that can cooperate with the SBE, the B site, or each other. Second, although the cooperative behavior of the artificial construct utilized in Fig. 6 (pTK SBE) appears to depend solely upon the SBE, data shown in Fig. 7 illustrate that such cooperativity is dependent upon a 25-base pair fragment of the TK promoter between positions 105 and 81. When the pTK-81 promoter was used with the isolated SBE, no cooperativity was evident. While we do not understand the mechanism(s) through which cooperativity occurs in this setting, the results suggest that the SBE is not independently capable of mediating cooperative response to IFN and TNF.

The molecular mechanisms involved in functional synergy between distinct transcription factors appear to be multifactorial (23, 59-63). In some cases, direct protein-protein interaction between activator proteins has been observed (23, 59). The physical interaction may result in cooperative DNA binding, more stable protein-DNA interactions, and/or increased affinity of one or both activator proteins, ultimately creating a highly stable multiprotein complex that has markedly enhanced functional properties (23, 63). In this regard, members of the NF-B and the STAT families have been observed to interact with members of other distinct factor families (21-23, 64, 65) although not with each other. Both NF-B and STAT1 formed complexes on the IRF-1 SBE, but these appeared to be independent interactions between individual factors and DNA, since each complex exhibited a distinct mobility in EMSA. Furthermore, the presence of one factor did not alter the interaction of the other with its cognate site, nor did the presence of both factors promote the formation of any unique complexes not detected in cells treated with either stimulus alone. Nevertheless, we cannot completely rule out the possibility that a weak interaction between STAT1 and NF-B in vivo might produce the observed functional cooperativity, since in vitro study of protein-protein interaction will only detect relatively high affinity interactions. Furthermore, analysis of nucleotide spacing between these sequence motifs indicated that, although spacial distances may quantitatively modify the response, the specific intervening nucleotide sequences were more important. This latter observation may suggest a role for other factors or an influence of flanking sequence on the functional behavior of transacting factors bound to DNA. This possibility is also supported by the finding that a single SBE motif could mediate moderate cooperative response to IFN and TNF when other stimulus-insensitive sites are present.

An alternative mechanism for transcriptional synergy might involve independent interaction of the activation domains of individual factors with components of the general transcription machinery such as the TATA-binding protein, TATA-binding protein-associated factors, TFIIA, and TFIIB (61, 62). The same activator domain may interact with more than one component of the RNA polymerase complex. These multiprotein interactions could facilitate assembly of a preinitiation complex, stabilize the complex on promoter DNA, and thus promote the frequency of transcriptional initiation and elongation. Members of the Rel family have been reported to interact directly with TATA-binding protein and TFIIB (66, 67), and thus it is conceivable that the activation domains of these factors and of STAT1 may differentially interact with basal transcription components.

FOOTNOTES

REFERENCES

1. Farrar, M. A., and Schreiber, R. D. (1993) Annu. Rev. Immunol. 11, 571-611 [CrossRef][Medline] [Order article via Infotrieve]
2. Tracey, K. J., and Cerami, A. (1993) Annu. Rev. Cell. Biol. 9, 317-343 [CrossRef]
3. Barker, J. N. W. N., Sarma, V., Mitra, R. S., Dixit, V. M., and Nickoloff, B. J. (1990) J. Clin. Invest. 85, 605-608
4. Johnson, D. R., and Pober, J. S. (1994) Mol. Cell. Biol. 14, 1322-1332 [Abstract/Free Full Text]
5. Ohmori, Y., and Hamilton, T. A. (1995) J. Immunol. 154, 5235-5244 [Abstract]
6. Marfaing-Koka, A., Devergne, O., Gorgone, G., Portier, A., Schall, T. J., Galanaud, P., and Emilie, D. (1995) J. Immunol. 154, 1870-1878 [Abstract]
7. Stewart, R. J., Kashour, T. S., and Marsden, P. A. (1996) J. Immunol. 156, 1221-1228 [Abstract]
8. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. (1994) Science 264, 1415-1421 [Abstract/Free Full Text]
9. Schindler, C., and Darnell, J. E., Jr. (1995) Annu. Rev. Biochem. 64, 621-651 [Medline] [Order article via Infotrieve]
10. Ihle, J. E., and Kerr, I. M. (1995) Trends Genet. 11, 69-74 [CrossRef][Medline] [Order article via Infotrieve]
11. Larner, A. C., and Finbloom, D. S. (1995) Biochim. Biophys. Acta 1266, 278-287 [Medline] [Order article via Infotrieve]
12. Seidel, H. M., Milocco, L. H., Lamb, P., Darnell, J. E., Jr., Stein, R. B., and Rosen, J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3041-3045 [Abstract/Free Full Text]
13. Decker, T., Lew, D. J., Mirkovitch, J., and Darnell, J. E., Jr. (1991) EMBO J. 10, 927-932 [Medline] [Order article via Infotrieve]
14. Sims, S. H., Cha, Y., Romine, M. F., Gao, P., Gottlieb, K., and Deisseroth, A. B. (1993) Mol. Cell. Biol. 13, 690-702 [Abstract/Free Full Text]
15. Pine, R., Canova, A., and Schindler, C. (1994) EMBO J. 13, 158-167 [Medline] [Order article via Infotrieve]
16. Caldenhoven, E., Coffer, P., Yuan, J., van de Stolpe, A., Horn, F., Kruijer, W., and Van Der Saag, P. T. (1994) J. Biol. Chem. 269, 21146-21154 [Abstract/Free Full Text]
17. Look, D. C., Pelletier, M. R., and Holtzman, M. J. (1994) J. Biol. Chem. 269, 8952-8958 [Abstract/Free Full Text]
18. Blank, V., Kourilsky, P., and Israel, A. (1992) Trends Biol. Sci. 17, 135-140
19. Grilli, M., Chiu, J. J.-S., and Leonardo, M. (1993) Int. Rev. Cytol. 143, 1-62 [Medline] [Order article via Infotrieve]
20. Baeuerle, P. A., and Henkel, T. (1994) Annu. Rev. Immunol. 12, 141-179 [Medline] [Order article via Infotrieve]
21. Matsusaka, T., Fujikawa, K., Nishino, Y., Mukaida, N., Matsushima, K., Kishimoto, T., and Akira, S. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 10193-10197 [Abstract/Free Full Text]
22. Stein, B., Cogswell, P. C., and Baldwin, A. S., Jr. (1993) Mol. Cell. Biol. 13, 3964-3974 [Abstract/Free Full Text]
23. Stein, B., and Baldwin, A. S., Jr. (1993) Mol. Cell. Biol. 13, 7191-7198 [Abstract/Free Full Text]
24. Meraz, M. A, White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., and Schreiber, R. D. (1996) Cell 84, 431-442 [CrossRef][Medline] [Order article via Infotrieve]
25. Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., and Taniguchi, T. (1988) Cell 54, 903-913 [CrossRef][Medline] [Order article via Infotrieve]
26. Ohmori, Y., and Hamilton, T. A. (1990) Biochem. Biophys. Res. Commun. 168, 1261-1267 [CrossRef][Medline] [Order article via Infotrieve]
27. Ballantyne, C. M., O'Brien, W. E., and Beaudet, A. L. (1989) Nucleic Acids Res. 17, 5853 [Free Full Text]
28. Farber, J. M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 5238-5242 [Abstract/Free Full Text]
29. Schall, T. J., Simpson, N. J., and Mak, J. Y. (1992) Eur. J. Immunol. 22, 1477-1481 [Medline] [Order article via Infotrieve]
30. Danoff, T. M., Lalley, P. A., Chang, Y. S., Heeger, P. S., and Neilson, E. G. (1994) J. Immunol. 152, 1182-1189 [Abstract]
31. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
32. Chirgwin, J. J., Przbyla, A. E., MacDonald, R. J., and Rutter, W. J. (1979) Biochemistry 18, 5294-5311 [CrossRef][Medline] [Order article via Infotrieve]
33. Ohmori, Y., and Hamilton, T. A. (1993) J. Biol. Chem. 268, 6677-6688 [Abstract/Free Full Text]
34. McKnight, S. L., Gavis, E. R., and Kingsbury, R. (1981) Cell 25, 385-398 [CrossRef][Medline] [Order article via Infotrieve]
35. Gorman, C. M., Moffat, L. F., and Howard, B. H. (1982) Mol. Cell. Biol. 2, 1044-1051 [Abstract/Free Full Text]
36. De Wet, J. R., Wood, K. V., Deluca, M., Helinski, D. R., and Subramani, S. (1987) Mol. Cell. Biol. 7, 725-737 [Abstract/Free Full Text]
37. Ohmori, Y., Tebo, J., Nedospasov, S., and Hamilton, T. A. (1994) J. Biol. Chem. 269, 17684-17690 [Abstract/Free Full Text]
38. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Nucleic Acids Res. 11, 1475-1489 [Abstract/Free Full Text]
39. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
40. Yamamoto, K., Okamoto, S., Mukaida, N., Murakami, S., Mai, M., and Matsushima, K. (1992) J. Biol. Chem. 267, 22506-22511 [Abstract/Free Full Text]
41. Wright, T. M., and Farber, J. M. (1991) J. Exp. Med. 173, 417-422 [Abstract/Free Full Text]
42. Wong, P., Severns, C. W., Guyer, N. B., and Wright, T. M. (1994) Mol. Cell. Biol. 14, 914-922 [Abstract/Free Full Text]
43. Guyer, N. B., Severns, C. W., Wong, P., Feghali, C. A., and Wright, T. M. (1995) J. Immunol. 155, 3472-3480 [Abstract]
44. Voraberger, G., Schafer, R., and Stratowa, C. (1991) J. Immunol. 147, 2777-2786 [Abstract/Free Full Text]
45. Ledebur, H. C., and Parks, T. P. (1995) J. Biol. Chem. 270, 933-943 [Abstract/Free Full Text]
46. Shin, H. S., Drysdale, B., Shin, M. L., Noble, P. W., Fisher, S. N., and Paznekas, W. A. (1994) Mol. Cell. Biol. 14, 2914-2925 [Abstract/Free Full Text]
47. Rathanaswami, P., Hachicha, M., Sakick, M., Schall, T. J., and McColl, S. R. (1993) J. Biol. Chem. 268, 5834-5839 [Abstract/Free Full Text]
48. Stellato, C., Beck, L. A., Gorgone, G. A., Proud, D., Schall, T. J., Ono, S. J., Lichtenstein, L. M., and Schleimer, R. P. (1995) J. Immunol. 155, 410-418 [Abstract]
49. Harada, H., Takahashi, E., Itoh, S., Harada, K., Hori, T., and Taniguchi, T. (1994) Mol. Cell. Biol. 14, 1500-1509 [Abstract/Free Full Text]
50. Rein, T., Muller, M., and Zorbas, H. (1994) Nucleic Acid Res. 15, 3033-3037
51. Deng, W., Ohmori, Y., and Hamilton, T. A. (1996) Cell. Immunol. 170, 20-24 [CrossRef][Medline] [Order article via Infotrieve]
52. Hsu, H., Xiong, J., and Goeddel, D. V. (1995) Cell 81, 495-504 [CrossRef][Medline] [Order article via Infotrieve]
53. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., Mak, T. W., Taniguchi, T., and Vilcek, J. (1994) Science 263, 1612-1615 [Abstract/Free Full Text]
54. Durbin, J. E., Hackenmiller, R., Simon, M. C., and Levy, D. E. (1996) Cell 84, 443-450 [CrossRef][Medline] [Order article via Infotrieve]
55. Rilley, J. L., Westerheide, S. D., Price, J. A., Brown, J. A., and Boss, J. M. (1995) Immunity 2, 533-543 [CrossRef][Medline] [Order article via Infotrieve]
56. Tanaka, N., Kawakami, T., and Taniguchi, T. (1993) Mol. Cell. Biol. 13, 4531-4538 [Abstract/Free Full Text]
57. Garoufalis, E., Kwan, I., Lin, R., Mustafa, A., Pepin, N., Roulston, A., Lacoste, J., and Hiscott, J. (1994) J. Virol. 68, 4707-4715 [Abstract/Free Full Text]
58. Neish, A. S., Read, M. A., Thanos, D., Pine, R., Maniatis, T., and Collins, T. (1995) Mol. Cell. Biol. 15, 2558-2569 [Abstract]
59. Du, W., Thanos, D., and Maniatis, T. (1993) Cell 74, 887-898 [CrossRef][Medline] [Order article via Infotrieve]
60. Tjian, R., and Maniatis, T. (1994) Cell 77, 5-8 [CrossRef][Medline] [Order article via Infotrieve]
61. Chi, T., Lieberman, P., Ellwood, K., and Carey, M. (1995) Nature 377, 254-257 [Medline] [Order article via Infotrieve]
62. Sauer, F., Hansen, S. K., and Tjian, R. (1995) Science 270, 1783-1788 [Abstract/Free Full Text]
63. Thanos, D., and Maniatis, T. (1995) Cell 83, 1091-1100 [CrossRef][Medline] [Order article via Infotrieve]
64. Schaefer, T. S., Sanders, L. K., and Nathans, D. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9097-9101 [Abstract/Free Full Text]
65. Look, D. C., Pelletier, M. R., Tidwell, R. M., Roswit, W. T., and Holtzman, M. J. (1995) J. Biol. Chem. 270, 30264-30267 [Abstract/Free Full Text]
66. Kerr, L. D., Ransone, L. J., Wamsley, P., Schmitt, M. J., Boyer, T. G., Zhou, Q., Berk, A. J., and Verma, I. M. (1993) Nature 365, 412-419 [CrossRef][Medline] [Order article via Infotrieve]
67. Xu, X., Prorock, C., Ishikawa, H., Maldonado, E., Ito, Y., and Gelinas, C. (1993) Mol. Cell. Biol. 13, 6733-6741 [Abstract/Free Full Text]
68. van de Stolpe, A., Caldenhoven, E., Stade, B. G., Koenderman, L., Raaijmakers, J. A. M., Johnson, J. P., and van der Saag, P. T. (1994) J. Biol. Chem. 269, 6185-6192 [Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				H. J. Kimura, R. Rocchi, M. A. Landek-Salgado, K. Suzuki, C. Y. Chen, M. Kimura, N. R. Rose, and P. Caturegli Influence of Signal Transducer and Activator of Transcription-1 Signaling on Thyroid Morphology and Function Endocrinology, July 1, 2009; 150(7): 3409 - 3416. [Abstract] [Full Text] [PDF]

				N. Kanda and S. Watanabe Leptin Enhances Human {beta}-Defensin-2 Production in Human Keratinocytes Endocrinology, October 1, 2008; 149(10): 5189 - 5198. [Abstract] [Full Text] [PDF]

				K. Mohib, S. Wang, Q. Guan, A. L. Mellor, H. Sun, C. Du, and A. M. Jevnikar Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury Am J Physiol Renal Physiol, July 1, 2008; 295(1): F226 - F234. [Abstract] [Full Text] [PDF]

				O. Tliba and Y. Amrani Airway Smooth Muscle Cell as an Inflammatory Cell: Lessons Learned from Interferon Signaling Pathways Proceedings of the ATS, January 1, 2008; 5(1): 106 - 112. [Abstract] [Full Text] [PDF]

				N. Kanda and S. Watanabe Histamine enhances the production of human -defensin-2 in human keratinocytes Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1916 - C1923. [Abstract] [Full Text] [PDF]

				C. Albanesi, H. R. Fairchild, S. Madonna, C. Scarponi, O. De Pita, D. Y. M. Leung, and M. D. Howell IL-4 and IL-13 Negatively Regulate TNF-{alpha}- and IFN-{gamma}-Induced beta-Defensin Expression through STAT-6, Suppressor of Cytokine Signaling (SOCS)-1, and SOCS-3 J. Immunol., July 15, 2007; 179(2): 984 - 992. [Abstract] [Full Text] [PDF]

				V. Vila-del Sol, M. D. Diaz-Munoz, and M. Fresno Requirement of tumor necrosis factor {alpha} and nuclear factor-{kappa}B in the induction by IFN-{gamma} of inducible nitric oxide synthase in macrophages J. Leukoc. Biol., January 1, 2007; 81(1): 272 - 283. [Abstract] [Full Text] [PDF]

				X. Zhu, M. S. Chang, R. C. Hsueh, R. Taussig, K. D. Smith, M. I. Simon, and S. Choi Dual Ligand Stimulation of RAW 264.7 Cells Uncovers Feedback Mechanisms That Regulate TLR-Mediated Gene Expression J. Immunol., October 1, 2006; 177(7): 4299 - 4310. [Abstract] [Full Text] [PDF]

				J. Liu and X. Ma Interferon Regulatory Factor 8 Regulates RANTES Gene Transcription in Cooperation with Interferon Regulatory Factor-1, NF-{kappa}B, and PU.1 J. Biol. Chem., July 14, 2006; 281(28): 19188 - 19195. [Abstract] [Full Text] [PDF]

				B. D. Medoff, J. C. Wain, E. Seung, R. Jackobek, T. K. Means, L. C. Ginns, J. M. Farber, and A. D. Luster CXCR3 and Its Ligands in a Murine Model of Obliterative Bronchiolitis: Regulation and Function. J. Immunol., June 1, 2006; 176(11): 7087 - 7095. [Abstract] [Full Text] [PDF]

				P. A. Ruiz and D. Haller Functional Diversity of Flavonoids in the Inhibition of the Proinflammatory NF-{kappa}B, IRF, and Akt Signaling Pathways in Murine Intestinal Epithelial Cells J. Nutr., March 1, 2006; 136(3): 664 - 671. [Abstract] [Full Text] [PDF]

				R. Zhou, S.-X. Zheng, W. Tang, P.-L. He, X.-Y. Li, Y.-F. Yang, Y.-C. Li, J.-G. Geng, and J.-P. Zuo Inhibition of Inducible Nitric-Oxide Synthase Expression by (5R)-5-Hydroxytriptolide in Interferon-{gamma}- and Bacterial Lipopolysaccharide-Stimulated Macrophages J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 121 - 128. [Abstract] [Full Text] [PDF]

				K. Nakamichi, M. Saiki, M. Sawada, M. Takayama-Ito, Y. Yamamuro, K. Morimoto, and I. Kurane Rabies Virus-Induced Activation of Mitogen-Activated Protein Kinase and NF-{kappa}B Signaling Pathways Regulates Expression of CXC and CC Chemokine Ligands in Microglia J. Virol., September 15, 2005; 79(18): 11801 - 11812. [Abstract] [Full Text] [PDF]

				J. Liu, X. Guan, and X. Ma Interferon Regulatory Factor 1 Is an Essential and Direct Transcriptional Activator for Interferon {gamma}-induced RANTES/CCl5 Expression in Macrophages J. Biol. Chem., July 1, 2005; 280(26): 24347 - 24355. [Abstract] [Full Text] [PDF]

				H. B. Kwak, S. W. Lee, H. M. Jin, H. Ha, S. H. Lee, S. Takeshita, S. Tanaka, H.-M. Kim, H.-H. Kim, and Z. H. Lee Monokine induced by interferon-{gamma} is induced by receptor activator of nuclear factor {kappa}B ligand and is involved in osteoclast adhesion and migration Blood, April 1, 2005; 105(7): 2963 - 2969. [Abstract] [Full Text] [PDF]

				V. Vila-del Sol and M. Fresno Involvement of TNF and NF-{kappa}B in the Transcriptional Control of Cyclooxygenase-2 Expression by IFN-{gamma} in Macrophages J. Immunol., March 1, 2005; 174(5): 2825 - 2833. [Abstract] [Full Text] [PDF]

				M. Thomas, C. E. Finnegan, K. M.-A. Rogers, J. W. Purcell, A. Trimble, P. G. Johnston, and M. P. Boland STAT1: A Modulator of Chemotherapy-induced Apoptosis Cancer Res., November 15, 2004; 64(22): 8357 - 8364. [Abstract] [Full Text] [PDF]

				I. M. Adcock, K. Ito, and P. J. Barnes Glucocorticoids: Effects on Gene Transcription Proceedings of the ATS, November 1, 2004; 1(3): 247 - 254. [Abstract] [Full Text] [PDF]

				B. Jaruga, F. Hong, W.-H. Kim, and B. Gao IFN-{gamma}/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1 Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G1044 - G1052. [Abstract] [Full Text] [PDF]

				K. Nakamichi, S. Inoue, T. Takasaki, K. Morimoto, and I. Kurane Rabies Virus Stimulates Nitric Oxide Production and CXC Chemokine Ligand 10 Expression in Macrophages through Activation of Extracellular Signal-Regulated Kinases 1 and 2 J. Virol., September 1, 2004; 78(17): 9376 - 9388. [Abstract] [Full Text] [PDF]

				G. C. Hildebrandt, K. M. Olkiewicz, L. A. Corrion, Y. Chang, S. G. Clouthier, C. Liu, and K. R. Cooke Donor-derived TNF-{alpha} regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation Blood, July 15, 2004; 104(2): 586 - 593. [Abstract] [Full Text] [PDF]

				L. Chen, D. Duricka, S. Nelson, S. Mukherjee, S. G. Bohnet, P. Taishi, J. A. Majde, and J. M. Krueger Influenza virus-induced sleep responses in mice with targeted disruptions in neuronal or inducible nitric oxide synthases J Appl Physiol, July 1, 2004; 97(1): 17 - 28. [Abstract] [Full Text] [PDF]

				M. Severgnini, S. Takahashi, L. M. Rozo, R. J. Homer, C. Kuhn, J. W. Jhung, G. Perides, M. Steer, P. M. Hassoun, B. L. Fanburg, et al. Activation of the STAT pathway in acute lung injury Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1282 - L1292. [Abstract] [Full Text] [PDF]

				S.-i. Yokota, T. Okabayashi, N. Yokosawa, and N. Fujii Growth Arrest of Epithelial Cells during Measles Virus Infection Is Caused by Upregulation of Interferon Regulatory Factor 1 J. Virol., May 1, 2004; 78(9): 4591 - 4598. [Abstract] [Full Text] [PDF]

				P. Proost, S. Verpoest, K. V. de Borne, E. Schutyser, S. Struyf, W. Put, I. Ronsse, B. Grillet, G. Opdenakker, and J. V. Damme Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-{gamma} in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids J. Leukoc. Biol., May 1, 2004; 75(5): 777 - 784. [Abstract] [Full Text] [PDF]

				Z. Yu and B. C. Kone The STAT3 DNA-Binding Domain Mediates Interaction with NF-{kappa}B p65 and Inducible Nitric Oxide Synthase Transrepression in Mesangial Cells J. Am. Soc. Nephrol., March 1, 2004; 15(3): 585 - 591. [Abstract] [Full Text] [PDF]

				Y. Qiao, S. Prabhakar, A. Canova, Y. Hoshino, M. Weiden, and R. Pine Posttranscriptional Inhibition of Gene Expression by Mycobacterium tuberculosis Offsets Transcriptional Synergism with IFN-{gamma} and Posttranscriptional Up-Regulation by IFN-{gamma} J. Immunol., March 1, 2004; 172(5): 2935 - 2943. [Abstract] [Full Text] [PDF]

				S. Aittomaki, J. Yang, E. W. Scott, M. C. Simon, and O. Silvennoinen Molecular basis of Stat1 and PU.1 cooperation in cytokine-induced Fc{gamma} receptor I promoter activation Int. Immunol., February 1, 2004; 16(2): 265 - 274. [Abstract] [Full Text] [PDF]

				K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume Interferon-{gamma}: an overview of signals, mechanisms and functions J. Leukoc. Biol., February 1, 2004; 75(2): 163 - 189. [Abstract] [Full Text] [PDF]

				P. C. Baer, B. Wegner, and H. Geiger Effects of mycophenolic acid on IL-6 expression of human renal proximal and distal tubular cells in vitro Nephrol. Dial. Transplant., January 1, 2004; 19(1): 47 - 52. [Abstract] [Full Text] [PDF]

				Y. Hoshiya, V. Gupta, H. Kawakubo, E. Brachtel, J. L. Carey, L. Sasur, A. Scott, P. K. Donahoe, and S. Maheswaran Mullerian Inhibiting Substance Promotes Interferon {gamma}-induced Gene Expression and Apoptosis in Breast Cancer Cells J. Biol. Chem., December 19, 2003; 278(51): 51703 - 51712. [Abstract] [Full Text] [PDF]

				A. Takuma, T. Kaneda, T. Sato, S. Ninomiya, M. Kumegawa, and Y. Hakeda Dexamethasone Enhances Osteoclast Formation Synergistically with Transforming Growth Factor-{beta} by Stimulating the Priming of Osteoclast Progenitors for Differentiation into Osteoclasts J. Biol. Chem., November 7, 2003; 278(45): 44667 - 44674. [Abstract] [Full Text] [PDF]

				M. Woods, E. G. Wood, S. C. Bardswell, D. Bishop-Bailey, S. Barker, S. J. Wort, J. A. Mitchell, and T. D. Warner Role for Nuclear Factor-{kappa}B and Signal Transducer and Activator of Transcription 1/Interferon Regulatory Factor-1 in Cytokine-Induced Endothelin-1 Release in Human Vascular Smooth Muscle Cells Mol. Pharmacol., October 1, 2003; 64(4): 923 - 931. [Abstract] [Full Text] [PDF]

				V. Veckman, M. Miettinen, S. Matikainen, R. Lande, E. Giacomini, E. M. Coccia, and I. Julkunen Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis J. Leukoc. Biol., September 1, 2003; 74(3): 395 - 402. [Abstract] [Full Text] [PDF]

				T. Klamp, U. Boehm, D. Schenk, K. Pfeffer, and J. C. Howard A Giant GTPase, Very Large Inducible GTPase-1, Is Inducible by IFNs J. Immunol., August 1, 2003; 171(3): 1255 - 1265. [Abstract] [Full Text] [PDF]

				C.-W. Chen, Y.-H. Chang, C.-J. Tsi, and W.-W. Lin Inhibition of IFN-{gamma}-Mediated Inducible Nitric Oxide Synthase Induction by the Peroxisome Proliferator-Activated Receptor {gamma} Agonist, 15-Deoxy-{Delta}12,14-Prostaglandin J2, Involves Inhibition of the Upstream Janus Kinase/STAT1 Signaling Pathway J. Immunol., July 15, 2003; 171(2): 979 - 988. [Abstract] [Full Text] [PDF]

				R. Lande, E. Giacomini, T. Grassi, M. E. Remoli, E. Iona, M. Miettinen, I. Julkunen, and E. M. Coccia IFN-{alpha}{beta} Released by Mycobacterium tuberculosis-Infected Human Dendritic Cells Induces the Expression of CXCL10: Selective Recruitment of NK and Activated T Cells J. Immunol., February 1, 2003; 170(3): 1174 - 1182. [Abstract] [Full Text] [PDF]

				M. Hiroi and Y. Ohmori The Transcriptional Coactivator CREB-binding Protein Cooperates with STAT1 and NF-kappa B for Synergistic Transcriptional Activation of the CXC Ligand 9/Monokine Induced by Interferon-gamma Gene J. Biol. Chem., January 3, 2003; 278(1): 651 - 660. [Abstract] [Full Text] [PDF]

				I. Arany, W. E. Whitehead, K. J. Grattendick, I. A. Ember, and S. K. Tyring Suppression of Growth by All-trans Retinoic Acid Requires Prolonged Induction of Interferon Regulatory Factor 1 in Cervical Squamous Carcinoma (SiHa) Cells Clin. Vaccine Immunol., September 1, 2002; 9(5): 1102 - 1106. [Abstract] [Full Text] [PDF]

				Y. Huang, P. M. Krein, D. A. Muruve, and B. W. Winston Complement Factor B Gene Regulation: Synergistic Effects of TNF-{alpha} and IFN-{gamma} in Macrophages J. Immunol., September 1, 2002; 169(5): 2627 - 2635. [Abstract] [Full Text] [PDF]

				W. Li, X. Liang, C. Kellendonk, V. Poli, and R. Taub STAT3 Contributes to the Mitogenic Response of Hepatocytes during Liver Regeneration J. Biol. Chem., August 2, 2002; 277(32): 28411 - 28417. [Abstract] [Full Text] [PDF]

				J.-L. Carsol, S. Gingras, and J. Simard Synergistic Action of Prolactin (PRL) and Androgen on PRL-Inducible Protein Gene Expression in Human Breast Cancer Cells: A Unique Model for Functional Cooperation between Signal Transducer and Activator of Transcription-5 and Androgen Receptor Mol. Endocrinol., July 1, 2002; 16(7): 1696 - 1710. [Abstract] [Full Text] [PDF]

				M. E. Remoli, E. Giacomini, G. Lutfalla, E. Dondi, G. Orefici, A. Battistini, G. Uze, S. Pellegrini, and E. M. Coccia Selective Expression of Type I IFN Genes in Human Dendritic Cells Infected with Mycobacterium tuberculosis J. Immunol., July 1, 2002; 169(1): 366 - 374. [Abstract] [Full Text] [PDF]

				L. H. Wong, H. Sim, M. Chatterjee-Kishore, I. Hatzinisiriou, R. J. Devenish, G. Stark, and S. J. Ralph Isolation and Characterization of a Human STAT1 Gene Regulatory Element. INDUCIBILITY BY INTERFERON (IFN) TYPES I AND II AND ROLE OF IFN REGULATORY FACTOR-1 J. Biol. Chem., May 24, 2002; 277(22): 19408 - 19417. [Abstract] [Full Text] [PDF]

				S. N. Georas, L. A. Beck, and C. Stellato What Is Eotaxin Doing in the Pleura? . Insights into Innate Immunity from Pleural Mesothelial Cells Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 384 - 387. [Full Text] [PDF]

				A. J. Ammit, A. L. Lazaar, C. Irani, G. M. O'Neill, N. D. Gordon, Y. Amrani, R. B. Penn, and R. A. Panettieri Jr. Tumor Necrosis Factor-alpha -Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth Muscle Cells . Modulation by Glucocorticoids and beta -Agonists Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 465 - 474. [Abstract] [Full Text] [PDF]

				S. Joos, C. K. Menz, G. Wrobel, R. Siebert, S. Gesk, S. Ohl, G. Mechtersheimer, L. Trumper, P. Moller, P. Lichter, et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2 Blood, February 15, 2002; 99(4): 1381 - 1387. [Abstract] [Full Text] [PDF]

				A. H. Wagner, M. Gebauer, B. Pollok-Kopp, and M. Hecker Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1 Blood, January 15, 2002; 99(2): 520 - 525. [Abstract] [Full Text] [PDF]

				J. Maier, C. Kincaid, A. Pagenstecher, and I. L. Campbell Regulation of Signal Transducer and Activator of Transcription and Suppressor of Cytokine-Signaling Gene Expression in the Brain of Mice with Astrocyte-Targeted Production of Interleukin-12 or Experimental Autoimmune Encephalomyelitis Am. J. Pathol., January 1, 2002; 160(1): 271 - 288. [Abstract] [Full Text] [PDF]

				L.-y. Yu-Lee Stimulation of interferon regulatory factor-1 by prolactin Lupus, October 1, 2001; 10(10): 691 - 699. [Abstract] [PDF]

				I. TEGEDER, J. PFEILSCHIFTER, and G. GEISSLINGER Cyclooxygenase-independent actions of cyclooxygenase inhibitors FASEB J, October 1, 2001; 15(12): 2057 - 2072. [Abstract] [Full Text] [PDF]

				S. Ellermann-Eriksen and V. Kruys Expression of TNF-{alpha} by Herpes Simplex Virus-Infected Macrophages Is Regulated by a Dual Mechanism: Transcriptional Regulation by NF-{kappa}B and Activating Transcription Factor 2/Jun and Translational Regulation Through the AU-Rich Region of the 3' Untranslated Region J. Immunol., August 15, 2001; 167(4): 2202 - 2208. [Abstract] [Full Text] [PDF]

				J. G. Bode, R. Fischer, D. Haussinger, L. Graeve, P. C. Heinrich, and F. Schaper The Inhibitory Effect of IL-1{beta} on IL-6-Induced {alpha}2-Macroglobulin Expression Is Due to Activation of NF-{kappa}B J. Immunol., August 1, 2001; 167(3): 1469 - 1481. [Abstract] [Full Text] [PDF]

				R. L. Robson, R. M. McLoughlin, J. Witowski, P. Loetscher, T. S. Wilkinson, S. A. Jones, and N. Topley Differential Regulation of Chemokine Production in Human Peritoneal Mesothelial Cells: IFN-{{gamma}} Controls Neutrophil Migration Across the Mesothelium In Vitro and In Vivo J. Immunol., July 15, 2001; 167(2): 1028 - 1038. [Abstract] [Full Text] [PDF]

				K. Streetz, B. Fregien, J. Plumpe, K. Korber, S. Kubicka, G. Sass, S. C. Bischoff, M. P. Manns, G. Tiegs, and C. Trautwein Dissection of the Intracellular Pathways in Hepatocytes Suggests a Role for Jun Kinase and IFN Regulatory Factor-1 in Con A-Induced Liver Failure J. Immunol., July 1, 2001; 167(1): 514 - 523. [Abstract] [Full Text] [PDF]

				R. W. Ganster, B. S. Taylor, L. Shao, and D. A. Geller Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B PNAS, June 28, 2001; (2001) 151239498. [Abstract] [Full Text] [PDF]

				M. Goto, L. V. Deriy, Y. J. Chen, D. W. A. Beno, M. R. Uhing, V. A. Jiyamapa-Serna, and R. E. Kimura TNF-{alpha} increases sensitivity to LPS in chronically catheterized rats Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2857 - H2862. [Abstract] [Full Text] [PDF]

				Y. Ohmori and T. A. Hamilton Requirement for STAT1 in LPS-induced gene expression in macrophages J. Leukoc. Biol., April 1, 2001; 69(4): 598 - 604. [Abstract] [Full Text]

				T. Musikacharoen, T. Matsuguchi, T. Kikuchi, and Y. Yoshikai NF-{{kappa}}B and STAT5 Play Important Roles in the Regulation of Mouse Toll-Like Receptor 2 Gene Expression J. Immunol., April 1, 2001; 166(7): 4516 - 4524. [Abstract] [Full Text] [PDF]

				K. Rouger, J.-P. Louboutin, M. Villanova, Y. Cherel, and M. Fardeau X-Linked Vacuolated Myopathy : TNF-{{alpha}} and IFN-{{gamma}} Expression in Muscle Fibers with MHC Class I on Sarcolemma Am. J. Pathol., February 1, 2001; 158(2): 355 - 359. [Abstract] [Full Text] [PDF]

				A. J. Ammit, R. K. Hoffman, Y. Amrani, A. L. Lazaar, D. W. P. Hay, T. J. Torphy, R. B. Penn, and R. A. Panettieri Jr. Tumor Necrosis Factor-alpha -Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth-Muscle Cells . Modulation by Cyclic Adenosine Monophosphate Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 794 - 802. [Abstract] [Full Text]

				D. Imanishi, K. Yamamoto, H. Tsushima, Y. Miyazaki, K. Kuriyama, M. Tomonaga, and T. Matsuyama Identification of a Novel Cytokine Response Element in the Human IFN Regulatory Factor-1 Gene Promoter J. Immunol., October 1, 2000; 165(7): 3907 - 3916. [Abstract] [Full Text] [PDF]

				J. B. Johnston, Y. Jiang, G. van Marle, M. B. Mayne, W. Ni, J. Holden, J. C. McArthur, and C. Power Lentivirus Infection in the Brain Induces Matrix Metalloproteinase Expression: Role of Envelope Diversity J. Virol., August 15, 2000; 74(16): 7211 - 7220. [Abstract] [Full Text]

				D. P. Widney, Y.-R. Xia, A. J. Lusis, and J. B. Smith The Murine Chemokine CXCL11 (IFN-Inducible T Cell {alpha} Chemoattractant) Is an IFN-{gamma}- and Lipopolysaccharide- Inducible Glucocorticoid-Attenuated Response Gene Expressed in Lung and Other Tissues During Endotoxemia J. Immunol., June 15, 2000; 164(12): 6322 - 6331. [Abstract] [Full Text] [PDF]

				J. Chung, E. S. Park, D. Kim, J. M. Suh, H. K. Chung, J. Kim, H. Kim, S. J. Park, O-Y. Kwon, H. K. Ro, et al. Thyrotropin Modulates Interferon-{gamma}-Mediated Intercellular Adhesion Molecule-1 Gene Expression by Inhibiting Janus Kinase-1 and Signal Transducer and Activator of Transcription-1 Activation in Thyroid Cells Endocrinology, June 1, 2000; 141(6): 2090 - 2097. [Abstract] [Full Text] [PDF]

				H. Saito, Y. Morita, M. Fujimoto, M. Narazaki, T. Naka, and T. Kishimoto IFN Regulatory Factor-1-Mediated Transcriptional Activation of Mouse STAT-Induced STAT Inhibitor-1 Gene Promoter by IFN-{gamma} J. Immunol., June 1, 2000; 164(11): 5833 - 5843. [Abstract] [Full Text] [PDF]

				M. Miettinen, A. Lehtonen, I. Julkunen, and S. Matikainen Lactobacilli and Streptococci Activate NF-{kappa}B and STAT Signaling Pathways in Human Macrophages J. Immunol., April 1, 2000; 164(7): 3733 - 3740. [Abstract] [Full Text] [PDF]

				M. B. Lachyankar, N. Sultana, C. M. Schonhoff, P. Mitra, W. Poluha, S. Lambert, P. J. Quesenberry, N. S. Litofsky, L. D. Recht, R. Nabi, et al. A Role for Nuclear PTEN in Neuronal Differentiation J. Neurosci., February 15, 2000; 20(4): 1404 - 1413. [Abstract] [Full Text] [PDF]

				G. Luo and L.-y. Yu-Lee Stat5b Inhibits NF{kappa}B-Mediated Signaling Mol. Endocrinol., January 1, 2000; 14(1): 114 - 123. [Abstract] [Full Text]

				Q.-P. Liu, K. Fruit, J. Ward, and P. H. Correll Negative Regulation of Macrophage Activation in Response to IFN-{gamma} and Lipopolysaccharide by the STK/RON Receptor Tyrosine Kinase J. Immunol., December 15, 1999; 163(12): 6606 - 6613. [Abstract] [Full Text] [PDF]

				C. Stellato, S. Matsukura, A. Fal, J. White, L. A. Beck, D. Proud, and R. P. Schleimer Differential Regulation of Epithelial-Derived C-C Chemokine Expression by IL-4 and the Glucocorticoid Budesonide J. Immunol., November 15, 1999; 163(10): 5624 - 5632. [Abstract] [Full Text] [PDF]

				S. Goenka, J. Youn, L. M. Dzurek, U. Schindler, L.-y. Yu-Lee, and M. Boothby Paired Stat6 C-Terminal Transcription Activation Domains Required Both for Inhibition of an IFN-Responsive Promoter and Trans-Activation J. Immunol., November 1, 1999; 163(9): 4663 - 4672. [Abstract] [Full Text] [PDF]

				E. E. Rollo, K. P. Kumar, N. C. Reich, J. Cohen, J. Angel, H. B. Greenberg, R. Sheth, J. Anderson, B. Oh, S. J. Hempson, et al. The Epithelial Cell Response to Rotavirus Infection J. Immunol., October 15, 1999; 163(8): 4442 - 4452. [Abstract] [Full Text] [PDF]

				S. Hussain, B. S. Zwilling, and W. P. Lafuse Mycobacterium avium Infection of Mouse Macrophages Inhibits IFN-{gamma} Janus Kinase-STAT Signaling and Gene Induction by Down-Regulation of the IFN-{gamma} Receptor J. Immunol., August 15, 1999; 163(4): 2041 - 2048. [Abstract] [Full Text] [PDF]

				L. I. McKay and J. A. Cidlowski Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-{kappa}B and Steroid Receptor-Signaling Pathways Endocr. Rev., August 1, 1999; 20(4): 435 - 459. [Abstract] [Full Text] [PDF]

				D. Mumberg, P. A. Monach, S. Wanderling, M. Philip, A. Y. Toledano, R. D. Schreiber, and H. Schreiber CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma PNAS, July 20, 1999; 96(15): 8633 - 8638. [Abstract] [Full Text] [PDF]

				R. Y. Liu, C. Fan, N. E. Olashaw, X. Wang, and K. S. Zuckerman Tumor Necrosis Factor-alpha -induced Proliferation of Human Mo7e Leukemic Cells Occurs via Activation of Nuclear Factor kappa B Transcription Factor J. Biol. Chem., May 14, 1999; 274(20): 13877 - 13885. [Abstract] [Full Text] [PDF]

				K. Saito, D. Kobayashi, M. Sasaki, H. Araake, T. Kida, A. Yagihashi, T. Yajima, H. Kameshima, and N. Watanabe Detection of Human Serum Tumor Necrosis Factor-{alpha} in Healthy Donors, Using a Highly Sensitive Immuno-PCR Assay Clin. Chem., May 1, 1999; 45(5): 665 - 669. [Abstract] [Full Text] [PDF]

				T. WELTE, D. LEITENBERG, B.N. DITTEL, B.K. AL-RAMADI, W.R. HANSEN, B. XIE, C.A. JANEWAY, A.L.M. BOTHWELL, K. BOTTOMLY, and X.Y. FU The PTK-STAT Signaling Pathway Has Essential Roles in T-cell Activation in Response to Antigen Stimulation Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 291 - 302. [Abstract] [PDF]

				I. Blasko, F. Marx, E. Steiner, T. Hartmann, and B. Grubeck-loebenstein TNF{alpha} plus IFN{gamma} induce the production of Alzheimer ฿-amyloid peptides and decrease the secretion of APPs FASEB J, January 1, 1999; 13(1): 63 - 68. [Abstract] [Full Text]

				F. Chen, V. Castranova, X. Shi, and L. M. Demers New Insights into the Role of Nuclear Factor-{kappa}B, a Ubiquitous Transcription Factor in the Initiation of Diseases Clin. Chem., January 1, 1999; 45(1): 7 - 17. [Abstract] [Full Text] [PDF]

				C. Albanesi, A. Cavani, and G. Girolomoni IL-17 Is Produced by Nickel-Specific T Lymphocytes and Regulates ICAM-1 Expression and Chemokine Production in Human Keratinocytes: Synergistic or Antagonist Effects with IFN-{gamma} and TNF-{alpha} J. Immunol., January 1, 1999; 162(1): 494 - 502. [Abstract] [Full Text] [PDF]

				M. R. Horton, C. M. McKee, C. Bao, F. Liao, J. M. Farber, J. Hodge-DuFour, E. Pure, B. L. Oliver, T. M. Wright, and P. W. Noble Hyaluronan Fragments Synergize with Interferon-gamma to Induce the C-X-C Chemokines Mig and Interferon-inducible Protein-10 in Mouse Macrophages J. Biol. Chem., December 25, 1998; 273(52): 35088 - 35094. [Abstract] [Full Text] [PDF]

				S. Gupta, D. Xia, M. Jiang, S. Lee, and A. B. Pernis Signaling Pathways Mediated by the TNF- and Cytokine-Receptor Families Target a Common cis-Element of the IFN Regulatory Factor 1 Promoter J. Immunol., December 1, 1998; 161(11): 5997 - 6004. [Abstract] [Full Text] [PDF]

				Y. Ohmori and T. A. Hamilton STAT6 Is Required for the Anti-inflammatory Activity of Interleukin-4 in Mouse Peritoneal Macrophages J. Biol. Chem., October 30, 1998; 273(44): 29202 - 29209. [Abstract] [Full Text] [PDF]

				A. L. Lazaar, Y. Amrani, J. Hsu, R. A. Panettieri Jr., W. C. Fanslow, S. M. Albelda, and E. Pure CD40-Mediated Signal Transduction in Human Airway Smooth Muscle J. Immunol., September 15, 1998; 161(6): 3120 - 3127. [Abstract] [Full Text] [PDF]

				B. S. Taylor, M. E. de Vera, R. W. Ganster, Q. Wang, R. A. Shapiro, S. M. Morris Jr., T. R. Billiar, and D. A. Geller Multiple NF-kappa B Enhancer Elements Regulate Cytokine Induction of the Human Inducible Nitric Oxide Synthase Gene J. Biol. Chem., June 12, 1998; 273(24): 15148 - 15156. [Abstract] [Full Text] [PDF]

				C.-H. Shen and J. Stavnezer Interaction of Stat6 and NF-kappa B: Direct Association and Synergistic Activation of Interleukin-4-Induced Transcription Mol. Cell. Biol., June 1, 1998; 18(6): 3395 - 3404. [Abstract] [Full Text]

				S. Mahalingam, G. Chaudhri, C. Ling Tan, A. John, P. S. Foster, and G. Karupiah Transcription of the Interferon gamma (IFN-gamma )-inducible Chemokine Mig in IFN-gamma -deficient Mice J. Biol. Chem., March 2, 2001; 276(10): 7568 - 7574. [Abstract] [Full Text] [PDF]

				Y. Ohmori and T. A. Hamilton Interleukin-4/STAT6 Represses STAT1 and NF-kappa B-dependent Transcription through Distinct Mechanisms J. Biol. Chem., November 22, 2000; 275(48): 38095 - 38103. [Abstract] [Full Text] [PDF]

				R. W. Ganster, B. S. Taylor, L. Shao, and D. A. Geller Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B PNAS, July 17, 2001; 98(15): 8638 - 8643. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohmori, Y. Articles by Hamilton, T. A. Search for Related Content PubMed PubMed Citation Articles by Ohmori, Y. Articles by Hamilton, T. A. Social Bookmarking                      What's this?